You are here

AstraZeneca

PhaseBio touts 'breakthrough' badge for bloodthinner reversal agent licensed from AstraZeneca, shares leap

Endpoints

Tue, 04/9/19 - 08:22 am

bloodthinner reversals

breakthrough status

The top 15 pharma companies by 2018 revenue

Fierce Pharma

Mon, 04/8/19 - 11:30 pm

Bristol-Myers Squibb

Gilead Sciences

Teva Pharmaceutical

AstraZeneca’s asthma drug Fasenra looks promising for a set of rare chronic immune diseases

Endpoints

Thu, 04/4/19 - 10:30 am

Early pancreatic cancer data give Clovis a new path in PARP market

Biopharma Dive

Tue, 04/2/19 - 04:22 pm

pancreatic cancer

Clovis Oncology

PARP inhibitors

AstraZeneca May Not Have the Cash Flow to Pull Off Its Big Expansion

Barron's

Tue, 04/2/19 - 12:01 pm

Circassia gets dual boost for US COPD drugs

Pharmaforum

Mon, 04/1/19 - 10:39 am

Chi-Med, AstraZeneca's savolitinib helps some Tagrisso-resistant EGFR lung cancer patients

Fierce Pharma

Sun, 03/31/19 - 03:44 pm

EGFR lung cancer

AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal

Yahoo/Reuters

Fri, 03/29/19 - 10:06 am

trastuzumab deruxtecan

Aveo Oncology Stock Spikes on Rumors of AstraZeneca Acquisition

BioSpace

Thu, 03/28/19 - 12:06 pm

AstraZeneca's Imfinzi gets a lift in lung cancer from England's cost watchdogs

Fierce Pharma

Thu, 03/28/19 - 11:50 am

AstraZeneca to help build new life science research cluster in China

Fierce Biotech

Thu, 03/28/19 - 11:38 am

AZ’s diabetes drug Forxiga approved in EU for type 1 disease

Pharmaforum

Mon, 03/25/19 - 10:17 am

type 1 diabetes diabetes

Microbiome Report for Week Ending 3/16/19

CP Wire

Fri, 03/22/19 - 10:01 am

Seres Therapeutics

Microbiome Report for Week Ending 3/16/19

Fri, 03/22/19 - 09:56 am

Seres Therapeutics

ACC: AstraZeneca's Farxiga chops follow-up CV events by 16% in heart attack patients with diabetes

Fierce Pharma

Mon, 03/18/19 - 12:16 pm

American College of Cardiology

3 Top Diabetes Stocks to Watch in March

Yahoo/Motley Fool

Sun, 03/17/19 - 08:04 pm

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

Yahoo/Benzinga

Sat, 03/16/19 - 12:25 pm

SAGE Therapeutics

Ligand Pharmaceuticals

Jazz Pharmaceuticals

Lexicon Pharmaceuticals

Leap Therapeutics

ExcepGen emerges from Y Combinator, taking aim at better proteins for drug discovery

Fierce Biotech

Fri, 03/15/19 - 08:35 pm

AstraZeneca lines up a $20M installment plan to launch a new oncology collaboration with microbiome player Seres

Endpoints

Mon, 03/11/19 - 10:13 pm

Seres Therapeutics

Was AstraZeneca CEO Pascal Soriot happy with his $14.8M in '18 compensation? Probably not so much

Endpoints

Tue, 03/5/19 - 12:01 pm

Pages